23/10/2023 - 14:04

Brain cancer survival hopes lifted in Chimeric trials

23/10/2023 - 14:04


Save articles for future reference.

There is new survival hope for people diagnosed with brain cancer after a positive response from patients engaged in a Chimeric Therapeutics trial designed to monitor the efficacy of its promising cell therapy for glioblastoma. The cancer fighter says more than half of its participating patients extended median survival expectations up to 10 months, with two patients demonstrating survival beyond 14 months.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options